Metabolite of the month – Arachidonic acid

by | Dec 17, 2020 | Blog, Infectiology, Literature

History & Evolution

1909: isolation from mammal tissues by Percival Hartley | 1940: definition of four double bonds locations (Martin et al. 2016)

Unlike its name suggests (derived from the Latin, arachis, meaning peanut), arachidonic acid is not present in high amounts in peanuts. This polyunsaturated fatty acid was named in 1913 after its saturated cousin, arachidic acid, which is commonly found in peanuts and other nuts (Martin et al. 2016). In contrast, arachidonic acid is rarely found in plants, but can be produced by many animal and microbial species (Abedi and Sahari 2014).

Biosynthesis vs. dietary uptake

Arachidonic acid (C20:4, standing for 20 carbons with 4 double bonds) is available in high amounts in foods of animal origin: meats, fish, dairy products and eggs (Mann et al. 1995; Taber et al. 1998; Abedi and Sahari 2014). In humans, arachidonic acid can be synthesized by elongation and saturation of linoleic acid (C18:2), an essential fatty acid. This means that a lack of linoleic acid can hinder processes requiring arachidonic acid. However, the degradation of phospholipids by phospholipases such as PLA2 can also be a source of arachidonic acid from endogenous metabolism. Both exogenous (dietary) and endogenous arachidonic acid may be used as substrates (Brash 2001).

Arachidonic acid and cellular membranes

The role of lipids in cellular organization and signalling is gaining momentum, putting fatty acids and complex lipids at the forefront of modern biomedical research.  As a fatty acid present in phospholipids, arachidonic acid plays an important role in cellular structure. Thanks to its four cis double bonds, it contributes to the flexibility of cellular membranes which is essential for cell function, particularly in the nervous system, skeletal muscle and immune system (Rich 1993; Tallima and El Ridi 2018).

Arachidonic acid, eicosanoids and inflammation

The four cis double bonds of arachidonic acid make it particularly prone to oxidation, from which eicosanoids are derived. This family of molecules includes prostaglandins, leukotrienes, and other lipids, which act as mediators and regulators of inflammation and wound healing. They also contribute to vascular tone, lipid metabolism, epithelial barrier function, pain, and more (Dennis and Norris 2015). For this reason, lipidomics is a popular method when investigating processes such as inflammation and anti-inflammatory therapies (Mazaleuskaya et al. 2016).

Arachidonic acid and the brain

Arachidonic acid and other polyunsaturated fatty acids (PUFA) are essential to brain development, repair, and maintenance, and to neuron protection (Liu et al. 2015). Although results are inconclusive, studies have explored the role of arachidonic acid and eicosanoids in depression (Lin et al. 2010; Gopaldas et al. 2019), amyotrophic lateral sclerosis (ALS) (Carter et al. 2020), Alzheimer’s disease (Snowden et al. 2017; Goozee et al. 2017), Parkinson’s disease (Willkommen et al. 2018) and bipolar disorder (Rapoport 2014). Research shows arachidonic acid supplements could also have a beneficial effect on cognitive dysfunction (Kotani et al. 2006).

Arachidonic acid supplements and athletes

The effects of arachidonic acid supplements have been investigated in fields as varied as neurology, cardiology, hepatology or nutrition (Kawashima 2019). But it is athletes that probably represent the largest market for arachidonic acid supplements. However, given the role of arachidonic acid in the regulation of inflammation, there are concerns about the safety of such supplements. Supplementation of the diet with arachidonic acid may help increase lean body mass, upper-body strength and peak power in trained males (De Souza E. O. et al. 2016). Studies on the effects of arachidonic acid supplements in resistance training also showed effects on skeletal muscle and blood lipid profiles and peak power without a significant induction of inflammation signalling (Markworth et al. 2018; Roberts et al. 2007).

Arachidonic acid and COVID-19

Recent metabolomic and lipidomic investigations on the effects of the SARS-CoV-2 virus revealed a link to imbalances in arachidonic acid and eicosanoid levels (Di Wu et al. 2020; Barberis et al. 2020). Arachidonic acid was identified as a marker of the severity of the disease (Barberis et al. 2020), leading the authors to conclude that PLA2 may be a potential target for the treatment of COVID-19. The suggested anti-viral properties of arachidonic acid and related metabolites also led to their recommendation as potential therapeutics (Shoieb et al. 2020; Das 2020).


Abedi E, Sahari MA: Long-chain polyunsaturated fatty acid sources and evaluation of their nutritional and functional properties (2014) Food science & nutrition | .

Barberis E, Timo S et al.: Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2 (2020) International journal of molecular sciences | .

Brash AR: Arachidonic acid as a bioactive molecule (2001) The Journal of clinical investigation | .

Carter GT, McLaughlin RJ et al.: Endocannabinoids and related lipids in serum from patients with amyotrophic lateral sclerosis (2020) Muscle & nerve | .

Das UN: Can Bioactive Lipids Inactivate Coronavirus (COVID-19)? (2020) Archives of medical research | .

De Souza EO, Lowery RP et al.: Effects of Arachidonic Acid Supplementation on Acute Anabolic Signaling and Chronic Functional Performance and Body Composition Adaptations (2016) PloS one | .

Dennis EA, Norris PC: Eicosanoid Storm in Infection and Inflammation (2015) Nature reviews Immunology | .

Wu D, Shu T et al.: Plasma metabolomic and lipidomic alterations associated with COVID-19 (2020) National Science Review | .

Goozee K, Chatterjee P et al.: Alterations in erythrocyte fatty acid composition in preclinical Alzheimer’s disease (2017) Scientific Reports | .

Gopaldas M, Zanderigo F et al.: Brain serotonin transporter binding, plasma arachidonic acid and depression severity: A positron emission tomography study of major depression (2019) Journal of Affective Disorders | .

Kawashima H: Intake of arachidonic acid-containing lipids in adult humans: dietary surveys and clinical trials (2019) Lipids in health and disease | 10.1186/s12944-019-1039-y .

Kotani S, Sakaguchi E et al.: Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction (2006) Neuroscience research | .

Lin PY, Huang SY & Su KP: A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression (2010) Biological psychiatry | .

Liu JJ, Green P et al.: Pathways of polyunsaturated fatty acid utilization: Implications for brain function in neuropsychiatric health and disease (2015) Brain Research |

Mann NJ, Johnson LG et al.: The arachidonic acid content of the Australian diet is lower than previously estimated (1995) The Journal of nutrition | .

Markworth JF, Mitchell CJ et al.: Arachidonic acid supplementation modulates blood and skeletal muscle lipid profile with no effect on basal inflammation in resistance exercise trained men (2018) Prostaglandins, leukotrienes, and essential fatty acids | .

Martin SA, Brash AR et al.: The discovery and early structural studies of arachidonic acid (2016) Journal of lipid research |

Mazaleuskaya, Liudmila L.; Lawson, John A.; Li, Xuanwen; Grant, Gregory; Mesaros, Clementina; Grosser, Tilo; Blair, Ian A.; Ricciotti, Emanuela; FitzGerald, Garret A.: A broad-spectrum lipidomics screen of antiinflammatory drug combinations in human blood (2016) JCI insight | .

Rapoport SI: Lithium and the other mood stabilizers effective in bipolar disorder target the rat brain arachidonic acid cascade (2014) ACS chemical neuroscience | .

Rich MR: Conformational analysis of arachidonic and related fatty acids using molecular dynamics simulations (1993) Biochimica et Biophysica Acta (BBA) – Molecular Cell Research | .

Roberts MD, Iosia M et al.: Effects of arachidonic acid supplementation on training adaptations in resistance-trained males (2007) Journal of the International Society of Sports Nutrition | .

Shoieb SM, El-Ghiaty MA et al.: Targeting arachidonic acid-related metabolites in COVID-19 patients: potential use of drug-loaded nanoparticles (2020) Emergent materials | .

Snowden SG, Ebshiana AA et al.: Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: A nontargeted metabolomic study (2017) PLoS medicine | .

Taber L, Chiu CH & Whelan J: Assessment of the arachidonic acid content in foods commonly consumed in the American diet (1998) Lipids | .

Willkommen D, Lucio M et al.: Metabolomic investigations in cerebrospinal fluid of Parkinson’s disease (2018) PloS one | .

Click here to take survey